Immunohistochemical Markers of CYP3A4 and CYP3A7: A New Tool Towards Personalized Pharmacotherapy of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) represents a major global health problem, since more than 90% of primary liver cancers worldwide are HCC. Most cases of HCC are secondary to viral hepatitis infection (hepatitis B or C), alcoholism and cirrhosis. Sorafenib, an oral tyrosine kinase inhibitor that suppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanni, D., Manchia, M., Lai, F., Gerosa, C., Ambu, R., Faa, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933826/
https://www.ncbi.nlm.nih.gov/pubmed/27349315
http://dx.doi.org/10.4081/ejh.2016.2614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933826/
https://www.ncbi.nlm.nih.gov/pubmed/27349315
http://dx.doi.org/10.4081/ejh.2016.2614

Ejemplares similares